Clinical Trials
- Heart/Cardiovascular
Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia: The PROMISE III Trial
- Ages18 years - 95 years
- GenderBoth
- Diabetes
Testing Ultrasound as a new Treatment for Diabetes
- Diabetes
Type 2 Diabetes Ultrasound Study
- Ages21 years - 75 years
- GenderBoth